Group 1 - The core viewpoint of the article is that Pumen Technology (688389.SH) is primarily conducting its consumer health online business through flagship stores on e-commerce platforms such as Tmall and JD.com, and currently has no collaboration with Ant Group's Aifu [1] Group 2 - The company is leveraging major e-commerce platforms for its online sales strategy [1] - There is no existing partnership with Ant Group's Aifu, indicating a potential area for future development or collaboration [1]

Group 1 - The core viewpoint of the article is that Pumen Technology (688389.SH) is primarily conducting its consumer health online business through flagship stores on e-commerce platforms such as Tmall and JD.com, and currently has no collaboration with Ant Group's Aifu [1] Group 2 - The company is leveraging major e-commerce platforms for its online sales strategy [1] - There is no existing partnership with Ant Group's Aifu, indicating a potential area for future collaboration or development [1]

Group 1 - The first extraordinary general meeting of shareholders for Shenzhen Pumen Technology Co., Ltd. was held on December 16, 2025, at the company's headquarters in Shenzhen [2] - All resolutions proposed during the meeting were approved, with no rejected proposals [2] - The meeting was convened by the board of directors and chaired by Chairman Liu Xiancheng, following legal and procedural requirements [2][3] Group 2 - The meeting included the attendance of all 9 current directors and 3 supervisors, along with the board secretary and senior management [3] - Several governance-related proposals were passed, including the cancellation of the supervisory board and amendments to the company's articles of association and related rules [4][5] - A proposal for the company to apply for a comprehensive credit limit from banks for the year 2026 was also approved [5] Group 3 - The company recently received two medical device registration certificates for in vitro diagnostic reagents from the Guangdong Provincial Drug Administration [9] - The registered products are composite quality control products that ensure the safety and effectiveness of the company's electrochemical luminescence detection system [9] - As of the announcement date, the company and its subsidiaries have obtained a total of 105 registration certificates for electrochemical luminescence detection reagents, enhancing its product competitiveness in the immunodiagnostic field [9]

证券日报网讯 12月16日晚间，普门科技发布公告称，公司2025年第一次临时股东大会审议通过《关于 取消监事会、修订〈公司章程〉及相关议事规则的议案》《关于修订部分公司治理制度的议案》《关于 2026年度公司向银行申请综合授信额度的议案》。 （文章来源：证券日报） ...

本次取得注册证的产品均为复合质控品，以样本测量程序对质控品进行测定， 将测定结果进行统计分析或与参考值（参考范围）比较，判断结果是否满足要求， 以此确保公司电化学发光检测系统的安全、有效。 证券代码：688389 证券简称：普门科技 公告编号：2025-085 深圳普门科技股份有限公司 关于自愿披露取得医疗器械注册证的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 深圳普门科技股份有限公司（以下简称"公司"）于近期收到了2个广东省 药品监督管理局颁发的《中华人民共和国医疗器械注册证（体外诊断试剂）》， 具体情况如下： | 产品名称 | 注册 | 注册证 | 注册证 | | | 预期用途 | | --- | --- | --- | --- | --- | --- | --- | | | 分类 | 编号 | 有效期至 | | | | | | | | | | | 适用于经公司配套校准品校准的全自动 | | 性激素类质 | 类 II | 粤械注准 | 年 2030 | | | 化学发光测定仪及配套试剂组成的公司 | | 控品 ...

北京市中伦（深圳）律师事务所 关于深圳普门科技股份有限公司 2025 年第一次临时股东大会的 法律意见书 二〇二五年十二月 致：深圳普门科技股份有限公司 北京市中伦（深圳）律师事务所（下称"本所"）接受深圳普门科技股份有限公 司（下称"公司"）的委托，指派律师出席公司 2025 年第一次临时股东大会（下称 "本次股东大会"），并根据《中华人民共和国公司法》（下称"《公司法》"）、《上市 公司股东会规则》（下称"《股东会规则》"）等法律、法规和规范性文件及公司现行 章程（下称"《公司章程》"）的有关规定，就本次股东大会的召集和召开程序、召集 人资格、出席和列席会议人员资格、表决程序及表决结果等事宜发表法律意见。 一、本次股东大会的召集和召开程序 为召开本次股东大会，公司董事会于 2025 年 11 月 28 日在《公司章程》规定及 中国证券监督管理委员会指定的信息披露媒体上公告了会议通知。该通知载明了会 议的召开方式、召开时间和召开地点，对会议议题的内容进行了充分披露，说明了 股东有权出席并可委托代理人出席和行使表决权，明确了会议的登记办法、有权出 席会议股东的股权登记日、会议联系人姓名和电话号码，符合《股东会 ...

证券代码：688389 证券简称：普门科技 公告编号：2025-084 深圳普门科技股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （二） 股东大会召开的地点：广东省深圳市龙华区求知东路 8 号普门科技总部 大厦 22 楼会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 97 | | --- | --- | | 普通股股东人数 | 97 | | 2、出席会议的股东所持有的表决权数量 | 241,730,729 | | 普通股股东所持有表决权数量 | 241,730,729 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比例 | 56.4151 | | （%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 56.4151 | （四） 表决方式是否符合《公司法》及公司章程的规定，大会主持情况等。 本次股东大会由董事会召集，由董事 ...

Core Viewpoint - The company, Pumen Technology (688389.SH), has recently received two medical device registration certificates from the Guangdong Provincial Drug Administration for in vitro diagnostic reagents, indicating a significant advancement in its product offerings [1] Group 1: Product Registration - The registered products are composite quality control products, specifically for sex hormone quality control and thyroid function quality control [1] - These products utilize sample measurement procedures to assess quality control items, ensuring the safety and effectiveness of the company's electrochemical luminescence detection system [1]

Core Viewpoint - Pumen Technology (688389.SH) has recently received two medical device registration certificates from the Guangdong Provincial Drug Administration for in vitro diagnostic reagents, indicating a significant regulatory approval for its products [1] Group 1: Product Registration - The company obtained registration certificates for two products: hormone quality control products and thyroid function quality control products [1] - Both registered products are composite quality control products, which are measured using sample measurement procedures [1] Group 2: Quality Assurance - The measurement results of the quality control products will undergo statistical analysis or comparison with reference values to determine if they meet the required standards [1] - This process ensures the safety and effectiveness of the company's electrochemical luminescence detection system [1]

Core Viewpoint - The company has received two medical device registration certificates from the Guangdong Provincial Drug Administration for in vitro diagnostic reagents, indicating a significant regulatory achievement in expanding its product offerings [1] Group 1: Regulatory Achievements - The company obtained two registration certificates for quality control products related to sex hormones and thyroid function, with registration numbers 20252401568 and 20252401569, valid until November 27, 2030 [1] - As of the announcement date, the company and its subsidiaries have secured a total of 105 registration certificates for electrochemical luminescence detection reagents [1]